:

Hector A Nieves Figueroa1, William Rodriguez Cintron2

  • 1Department of Pulmonary and Critical Care Medicine, Veterans Affairs (VA) Caribbean Healthcare System, San Juan, PRI.

Cureus
|June 25, 2025
PubMed
概括

卡普马提尼布的向治疗显示,在患有MET外显子14跳转突变的晚期非小细胞肺癌 (NSCLC) 的老年患者中,可持续控制疾病. 分子分析对于识别NSCLC中这些可操作的目标至关重要.